ING Groep NV Sells 18,054 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

ING Groep NV reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.0% in the 4th quarter, Holdings Channel reports. The firm owned 54,194 shares of the medical equipment provider’s stock after selling 18,054 shares during the quarter. ING Groep NV’s holdings in Intuitive Surgical were worth $28,287,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $26,000. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth $36,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the third quarter worth $38,000. Finally, DT Investment Partners LLC raised its stake in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,348 shares of company stock worth $3,587,582. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.3 %

Shares of ISRG opened at $606.57 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $216.05 billion, a P/E ratio of 94.63, a price-to-earnings-growth ratio of 5.79 and a beta of 1.39. The stock’s 50-day moving average price is $564.41 and its two-hundred day moving average price is $523.46.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research reports. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. BTIG Research raised their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.